SynKIR-310 for Relapsed/Refractory B-NHL
Verismo Therapeutics
Verismo Therapeutics
National Institutes of Health Clinical Center (CC)
Stanford University
Poseida Therapeutics, Inc.
LTZ Therapeutics, Inc.
University Health Network, Toronto
University of Arizona
Mayo Clinic
Chengdu Zenitar Biomedical Technology Co., Ltd
University of Nebraska
Florida International University
Shanghai Exuma Biotechnology Ltd.